BPA - HPLC/UHPLC and GC-MS Systems

BPA - HPLC/UHPLC and GC-MS Systems Base + 4 OY The acquisition of new HPL>C/UHPLC and GC-MS systems will provide several benefits to OLOAS operations. First these advanced instruments will increase sample throughput by enabling faster analysis times and the capability to process multiple samples simultaneously. Second, the new system will enhance OLOAS laboratory's efficiency and speed in conducting complex chemical analyses, including multi-residue screening and targeted quantitative methods. Third, the improved instrumentation will lead to an overall enhanced sample flow process for regulatory samples, reducing turnaround times and enabli8ng more rapid regulatory decision-making. Additionally, modern HPLC/UHPLC and GC-MS systems offer improved sensitivity, selectivity, and reliability, which will strengthen the quality and defensibility of analytical results supporting FDA's regulatory actions.

Estimated value

>= $7M and < $13M

Est. solicitation date

Dec 1, 2025

Anticipated award

Jun 1, 2026

• NAICS334516
• PSC334516